107 related articles for article (PubMed ID: 27484097)
1. Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions.
Suzuki K; Yokoyama J; Kawauchi Y; Honda Y; Sato H; Aoyagi Y; Terai S; Okazaki K; Suzuki Y; Sameshima Y; Fukushima T; Sugahara K; Atreya R; Neurath MF; Watanabe K; Yoneyama H; Asakura H
J Crohns Colitis; 2017 Feb; 11(2):221-228. PubMed ID: 27484097
[TBL] [Abstract][Full Text] [Related]
2. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
3. Effects of EUS-guided intratumoral injection of oligonucleotide STNM01 on tumor growth, histology, and overall survival in patients with unresectable pancreatic cancer.
Nishimura M; Matsukawa M; Fujii Y; Matsuda Y; Arai T; Ochiai Y; Itoi T; Yahagi N
Gastrointest Endosc; 2018 Apr; 87(4):1126-1131. PubMed ID: 29122598
[TBL] [Abstract][Full Text] [Related]
4. New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease.
Suzuki K; Yoneyama H
Ann Transl Med; 2017 Apr; 5(8):191. PubMed ID: 28616406
[TBL] [Abstract][Full Text] [Related]
5. STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial.
Fujisawa T; Tsuchiya T; Kato M; Mizuide M; Takakura K; Nishimura M; Kutsumi H; Matsuda Y; Arai T; Ryozawa S; Itoi T; Isayama H; Saya H; Yahagi N
EClinicalMedicine; 2023 Jan; 55():101731. PubMed ID: 36425867
[TBL] [Abstract][Full Text] [Related]
6. Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis.
Suzuki K; Arumugam S; Yokoyama J; Kawauchi Y; Honda Y; Sato H; Aoyagi Y; Terai S; Okazaki K; Suzuki Y; Mizumoto S; Sugahara K; Atreya R; Neurath MF; Watanabe K; Hashiguchi T; Yoneyama H; Asakura H
PLoS One; 2016; 11(7):e0158967. PubMed ID: 27410685
[TBL] [Abstract][Full Text] [Related]
7. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
[TBL] [Abstract][Full Text] [Related]
8. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
[TBL] [Abstract][Full Text] [Related]
9. Prevention of esophageal stricture after endoscopic submucosal dissection using RNA-based silencing of carbohydrate sulfotransferase 15 in a porcine model.
Sato H; Sagara S; Nakajima N; Akimoto T; Suzuki K; Yoneyama H; Terai S; Yahagi N
Endoscopy; 2017 May; 49(5):491-497. PubMed ID: 28264215
[No Abstract] [Full Text] [Related]
10. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease.
Bouguen G; Levesque BG; Pola S; Evans E; Sandborn WJ
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):978-85. PubMed ID: 24246770
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
13. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
[TBL] [Abstract][Full Text] [Related]
14. Definition and evaluation of mucosal healing in clinical practice.
Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
[TBL] [Abstract][Full Text] [Related]
15. Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.
Atreya R; Kühbacher T; Waldner MJ; Hirschmann S; Drvarov O; Abu Hashem R; Maaser C; Kucharzik T; Dinter J; Mertens J; Schramm C; Holler B; Mössner J; Suzuki K; Yokoyama J; Terai S; Uter W; Yoneyama H; Asakura H; Hibi T; Neurath MF
J Crohns Colitis; 2024 Mar; 18(3):406-415. PubMed ID: 37777210
[TBL] [Abstract][Full Text] [Related]
16. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
[TBL] [Abstract][Full Text] [Related]
17. Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
Dignass A; Stoynov S; Dorofeyev AE; Grigorieva GA; Tomsová E; Altorjay I; Tuculanu D; Bunganič I; Pokrotnieks J; Kupčinskas L; Dilger K; Greinwald R; Mueller R;
J Crohns Colitis; 2014 Sep; 8(9):970-80. PubMed ID: 24534142
[TBL] [Abstract][Full Text] [Related]
18. The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease.
Rismo R; Olsen T; Ciu G; Paulssen EJ; Christiansen I; Florholmen J; Goll R
Scand J Gastroenterol; 2012 Oct; 47(10):1200-10. PubMed ID: 22861799
[TBL] [Abstract][Full Text] [Related]
19. PillCam COLON 2 in Crohn's disease: A new concept of pan-enteric mucosal healing assessment.
Boal Carvalho P; Rosa B; Dias de Castro F; Moreira MJ; Cotter J
World J Gastroenterol; 2015 Jun; 21(23):7233-41. PubMed ID: 26109810
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity.
Klimczak K; Lykowska-Szuber L; Eder P; Krela-Kazmierczak I; Stawczyk-Eder K; Szymczak A; Michalak M; Studniarek A; Linke K
Eur J Intern Med; 2015 Oct; 26(8):623-7. PubMed ID: 26198785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
